A U.S. cannabis company has expressed interest in acquiring Aurora Cannabis Inc., prompting the Edmonton-based firm to form a special committee to review the unsolicited bid. Curaleaf Holdings Inc. revealed its intention to purchase all shares of Aurora, aiming to create a combined cannabis entity operating in 17 countries across Europe, North America, and other global markets.
Curaleaf, based in Stamford, Conn., disclosed its plan after unsuccessful attempts to negotiate privately with Aurora’s leadership. Despite sending formal letters of intent on June 23 and July 7, outlining financial terms and proposals, Aurora’s board reportedly declined to engage in discussions with Curaleaf.
In response, Curaleaf’s CEO expressed disappointment at the lack of engagement and emphasized the significant premium and strategic benefits of the proposed transaction. The company remains open to constructive dialogue with Aurora’s board to finalize a mutually beneficial agreement.
Curaleaf proposed a payment of $4 US per share to Aurora shareholders, along with an additional $0.75 US in cash for each share. Aurora confirmed receiving the letters from Curaleaf but disputed the claim of refusing to engage with the offer. The Canadian company’s independent director communicated with Curaleaf’s CEO as recently as July 24, expressing a focus on executing its business plan and maintaining ongoing dialogue.
Aurora plans to establish a special committee of independent directors to evaluate the proposal’s alignment with stakeholder interests. While acknowledging Curaleaf’s interest, Aurora emphasized that the current offer undervalues its long-term potential. Analysts also echoed this sentiment, citing Aurora’s market leadership, product portfolio, and regulatory capabilities as factors that could deliver greater value over time.
Curaleaf highlighted the value in merging with Aurora, citing synergies in global distribution, medical cannabis operations, and cost savings. The companies collectively generated over $1.5 billion US in revenue in the past year, with expected annual cost synergies of at least $40 million US post-acquisition. The proposed merger aims to provide Aurora shareholders with enhanced exposure to global markets and regulatory opportunities, creating a diversified and robust platform.
Both companies will continue normal operations as discussions progress, with no guarantees of reaching a definitive agreement. The potential merger represents a strategic opportunity for growth and value creation, subject to further evaluation by Aurora’s special committee.
